Loading...

Welcome to the Regeneron COVID-19 Dashboard

This dashboard contains aggregated information on SARS-CoV-2 (hCoV-19) genomes and associated patient metadata, gathered in partnership with the GISAID initiative.

The goal of the dashboard is to enable scientists to understand the evolution of this emerging coronavirus by monitoring and displaying pertinent information. For example, the dashboard displays the novel mutations in SARS-CoV-2 (hCoV-19) genomes across time and geographical location, which facilitates the identification of a mutation that may increase transmission or virulence.

In addition, there is de-identified patient demographic information such as country of origin, patient status, and age, which provides further insights into the populations most susceptible to the virus.

3,653,571

SARS-CoV-2 (hCoV-19) genomes


September 20, 2021

04:05 AM ET

Last data update


Top Lineages Per Country (Past 12 Weeks)

Loading...

Top* Lineages (Past 12 Weeks)

Lineage Country Percent Lineage Count Total Count
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (64%), P681R, R158-, T19R
Estonia 89% 942 1,063
AY.4AY.4 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G (86%), F157- (86%), G142D (58%), P681R, R158- (86%), T19R, T95I (73%)
Lithuania 83% 3,412 4,094
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (64%), P681R, R158-, T19R
Montenegro 82% 73 89
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (64%), P681R, R158-, T19R
Croatia 79% 757 963
AY.4AY.4 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G (86%), F157- (86%), G142D (58%), P681R, R158- (86%), T19R, T95I (73%)
Austria 77% 1,621 2,104
AY.4AY.4 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G (86%), F157- (86%), G142D (58%), P681R, R158- (86%), T19R, T95I (73%)
United Kingdom 75% 203,235 272,529
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (64%), P681R, R158-, T19R
Norway 70% 3,069 4,355
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (64%), P681R, R158-, T19R
France 70% 16,972 24,360
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (64%), P681R, R158-, T19R
Turkey 69% 34,332 49,636
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (64%), P681R, R158-, T19R
Czechia 69% 1,075 1,565
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (64%), P681R, R158-, T19R
Spain 66% 8,807 13,360
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (64%), P681R, R158-, T19R
Italy 65% 8,259 12,658
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (64%), P681R, R158-, T19R
Sweden 65% 10,733 16,597
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (64%), P681R, R158-, T19R
Belgium 64% 7,220 11,206
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (64%), P681R, R158-, T19R
Russia 61% 219 358
AY.4AY.4 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G (86%), F157- (86%), G142D (58%), P681R, R158- (86%), T19R, T95I (73%)
Ireland 59% 5,155 8,810
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (64%), P681R, R158-, T19R
Switzerland 58% 8,803 15,284
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (64%), P681R, R158-, T19R
Germany 56% 23,035 41,052
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (64%), P681R, R158-, T19R
Bulgaria 54% 340 635
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (64%), P681R, R158-, T19R
Netherlands 53% 6,790 12,771
AY.12AY.12 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G (83%), F157- (84%), P681R, R158- (83%), T19R
Finland 53% 1,798 3,416
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (64%), P681R, R158-, T19R
Denmark 52% 22,114 42,912
AY.9AY.9 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)A222V, D614G, D950N, E156G, F157-, G142D (60%), P681R, R158-, T19R
Iceland 48% 1,794 3,722
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (64%), P681R, R158-, T19R
Portugal 48% 1,971 4,105
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (64%), P681R, R158-, T19R
Romania 44% 341 772
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (64%), P681R, R158-, T19R
Slovenia 44% 2,132 4,854
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (64%), P681R, R158-, T19R
Slovakia 43% 647 1,522
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (64%), P681R, R158-, T19R
Poland 42% 709 1,674
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (64%), P681R, R158-, T19R
Luxembourg 42% 399 956
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (64%), P681R, R158-, T19R
Finland 38% 1,305 3,416
AY.4AY.4 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G (86%), F157- (86%), G142D (58%), P681R, R158- (86%), T19R, T95I (73%)
Gibraltar 38% 329 871
AY.9AY.9 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)A222V, D614G, D950N, E156G, F157-, G142D (60%), P681R, R158-, T19R
Greece 37% 249 670
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (64%), P681R, R158-, T19R
Greece 35% 237 670
AY.4AY.4 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G (86%), F157- (86%), G142D (58%), P681R, R158- (86%), T19R, T95I (73%)
Slovenia 35% 1,684 4,854
AY.4AY.4 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G (86%), F157- (86%), G142D (58%), P681R, R158- (86%), T19R, T95I (73%)
Slovakia 33% 506 1,522
AY.4AY.4 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G (86%), F157- (86%), G142D (58%), P681R, R158- (86%), T19R, T95I (73%)
Bulgaria 33% 208 635
AY.4AY.4 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G (86%), F157- (86%), G142D (58%), P681R, R158- (86%), T19R, T95I (73%)
Poland 32% 543 1,674
P.1P.1 Mutations
ProteinMutations
Spike (RBD)E484K, K417T, N501Y
Spike (non-RBD)D138Y, D614G, H655Y, L18F, P26S, R190S, T20N, T1027I, V1176F
Luxembourg 30% 289 956
AY.12AY.12 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G (83%), F157- (84%), P681R, R158- (83%), T19R
Russia 30% 107 358
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (64%), P681R, R158-, T19R
Iceland 26% 974 3,722
AY.9AY.9 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)A222V, D614G, D950N, E156G, F157-, G142D (60%), P681R, R158-, T19R
Netherlands 26% 3,312 12,771
AY.4AY.4 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G (86%), F157- (86%), G142D (58%), P681R, R158- (86%), T19R, T95I (73%)
Romania 23% 177 772
AY.9AY.9 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)A222V, D614G, D950N, E156G, F157-, G142D (60%), P681R, R158-, T19R
Gibraltar 23% 198 871
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (64%), P681R, R158-, T19R
Gibraltar 22% 189 871
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (64%), P681R, R158-, T19R
Ireland 20% 1,772 8,810
AY.4AY.4 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G (86%), F157- (86%), G142D (58%), P681R, R158- (86%), T19R, T95I (73%)
Switzerland 17% 2,613 15,284
AY.5AY.5 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G (87%), F157- (88%), G142D (68%), P681R, R158- (87%), T19R
Luxembourg 17% 162 956
AY.4AY.4 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G (86%), F157- (86%), G142D (58%), P681R, R158- (86%), T19R, T95I (73%)
Denmark 16% 7,043 42,912
AY.4AY.4 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G (86%), F157- (86%), G142D (58%), P681R, R158- (86%), T19R, T95I (73%)
Czechia 15% 237 1,565
AY.4AY.4 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G (86%), F157- (86%), G142D (58%), P681R, R158- (86%), T19R, T95I (73%)
Germany 15% 6,105 41,052
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (64%), P681R, R158-, T19R
United Kingdom 15% 40,213 272,529
AY.12AY.12 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G (83%), F157- (84%), P681R, R158- (83%), T19R
Portugal 14% 568 4,105
AY.12AY.12 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G (83%), F157- (84%), P681R, R158- (83%), T19R
Germany 13% 5,489 41,052
AY.7.1AY.7.1 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G (63%), F157- (63%), P681R, R158- (63%), T19R
Denmark 12% 5,335 42,912
AY.5AY.5 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G (87%), F157- (88%), G142D (68%), P681R, R158- (87%), T19R
Portugal 12% 508 4,105
AY.9AY.9 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)A222V, D614G, D950N, E156G, F157-, G142D (60%), P681R, R158-, T19R
Romania 12% 95 772
AY.4AY.4 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G (86%), F157- (86%), G142D (58%), P681R, R158- (86%), T19R, T95I (73%)
Iceland 12% 449 3,722
AY.4AY.4 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G (86%), F157- (86%), G142D (58%), P681R, R158- (86%), T19R, T95I (73%)
Spain 12% 1,608 13,360
AY.4AY.4 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G (86%), F157- (86%), G142D (58%), P681R, R158- (86%), T19R, T95I (73%)
Italy 12% 1,512 12,658
AY.4AY.4 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G (86%), F157- (86%), G142D (58%), P681R, R158- (86%), T19R, T95I (73%)
Portugal 12% 486 4,105
AY.12AY.12 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G (83%), F157- (84%), P681R, R158- (83%), T19R
Romania 12% 91 772
AY.9AY.9 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)A222V, D614G, D950N, E156G, F157-, G142D (60%), P681R, R158-, T19R
Slovakia 12% 179 1,522
AY.4AY.4 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G (86%), F157- (86%), G142D (58%), P681R, R158- (86%), T19R, T95I (73%)
Netherlands 11% 1,432 12,771
AY.4AY.4 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G (86%), F157- (86%), G142D (58%), P681R, R158- (86%), T19R, T95I (73%)
Belgium 11% 1,256 11,206
B.1B.1 Mutations
ProteinMutations
Spike (non-RBD)D614G
Turkey 11% 5,539 49,636
AY.4AY.4 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G (86%), F157- (86%), G142D (58%), P681R, R158- (86%), T19R, T95I (73%)
Norway 11% 464 4,355
AY.4AY.4 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G (86%), F157- (86%), G142D (58%), P681R, R158- (86%), T19R, T95I (73%)
Sweden 11% 1,745 16,597
AY.12AY.12 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G (83%), F157- (84%), P681R, R158- (83%), T19R
Poland 11% 176 1,674
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (64%), P681R, R158-, T19R
Lithuania 10% 419 4,094
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (64%), P681R, R158-, T19R
Austria 10% 211 2,104
*Criteria: Above 10%, minimum of 50 samples per country.
Lineage Country Percent Lineage Count Total Count
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (64%), P681R, R158-, T19R
Guadeloupe 70% 117 168
B.1.1.7B.1.1.7 Mutations
ProteinMutations
Spike (RBD)N501Y
Spike (non-RBD)A570D, D614G, D1118H, H69-, P681H, S982A, T716I, V70-, Y144-
France (Martinique) 61% 77 126
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (64%), P681R, R158-, T19R
United States 57% 171,882 301,701
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (64%), P681R, R158-, T19R
The Bahamas 54% 32 59
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (64%), P681R, R158-, T19R
Canada 51% 5,557 10,891
AY.20AY.20 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N (90%), E156G, F157-, P681R, R158-, T19R, T95I (66%), V1104L
Mexico 50% 3,725 7,409
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (64%), P681R, R158-, T19R
Guatemala 50% 61 123
B.1.1.7B.1.1.7 Mutations
ProteinMutations
Spike (RBD)N501Y
Spike (non-RBD)A570D, D614G, D1118H, H69-, P681H, S982A, T716I, V70-, Y144-
Martinique 49% 73 150
AY.9AY.9 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)A222V, D614G, D950N, E156G, F157-, G142D (60%), P681R, R158-, T19R
Sint Maarten 45% 443 976
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (64%), P681R, R158-, T19R
Martinique 45% 68 150
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (64%), P681R, R158-, T19R
Puerto Rico 40% 341 846
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (64%), P681R, R158-, T19R
Sint Maarten 40% 386 976
B.1.1.7B.1.1.7 Mutations
ProteinMutations
Spike (RBD)N501Y
Spike (non-RBD)A570D, D614G, D1118H, H69-, P681H, S982A, T716I, V70-, Y144-
The Bahamas 37% 22 59
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (64%), P681R, R158-, T19R
U.S. Virgin Islands 36% 75 207
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (64%), P681R, R158-, T19R
Costa Rica 36% 119 329
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (64%), P681R, R158-, T19R
France (Martinique) 35% 44 126
AY.3AY.3 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (54%), P681R, R158-, T19R
Puerto Rico 34% 290 846
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (64%), P681R, R158-, T19R
Mexico 33% 2,448 7,409
AY.25AY.25 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (52%), P681R, R158-, T19R
U.S. Virgin Islands 28% 58 207
AY.25AY.25 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (52%), P681R, R158-, T19R
Canada 18% 2,005 10,891
P.1P.1 Mutations
ProteinMutations
Spike (RBD)E484K, K417T, N501Y
Spike (non-RBD)D138Y, D614G, H655Y, L18F, P26S, R190S, T20N, T1027I, V1176F
Costa Rica 16% 53 329
B.1.1.7B.1.1.7 Mutations
ProteinMutations
Spike (RBD)N501Y
Spike (non-RBD)A570D, D614G, D1118H, H69-, P681H, S982A, T716I, V70-, Y144-
Guadeloupe 15% 26 168
AY.25AY.25 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (52%), P681R, R158-, T19R
United States 14% 42,139 301,701
B.1.628B.1.628 Mutations
ProteinMutations
Spike (RBD)N440K (63%)
Spike (non-RBD)A688V (83%), D614G, L18R (81%), P681H, R158S (83%), S735A (84%), T95I (84%), T1027I (85%)
Guatemala 14% 17 123
AY.4AY.4 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G (86%), F157- (86%), G142D (58%), P681R, R158- (86%), T19R, T95I (73%)
Costa Rica 13% 42 329
B.1.1.7B.1.1.7 Mutations
ProteinMutations
Spike (RBD)N501Y
Spike (non-RBD)A570D, D614G, D1118H, H69-, P681H, S982A, T716I, V70-, Y144-
U.S. Virgin Islands 13% 26 207
A.2.5A.2.5 Mutations
ProteinMutations
Spike (RBD)L452R
Spike (non-RBD)D215A (55%), D614G, G142- (74%), L141- (73%), V143- (74%), ins215AGY (54%)
Guatemala 11% 14 123
AY.12AY.12 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G (83%), F157- (84%), P681R, R158- (83%), T19R
Canada 11% 1,173 10,891
AY.25AY.25 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (52%), P681R, R158-, T19R
Puerto Rico 10% 86 846
B.1.621B.1.621 Mutations
ProteinMutations
Spike (RBD)E484K, N501Y, R346K
Spike (non-RBD)D614G, D950N (90%), P681H, T95I, Y144T (77%), Y145S (70%), ins145N (76%)
Costa Rica 10% 33 329
*Criteria: Above 10%, minimum of 50 samples per country.
Lineage Country Percent Lineage Count Total Count
AY.23AY.23 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N (89%), E156G (79%), F157- (79%), G142D (58%), P681R, R158- (79%), T19R, V1264L (78%)
Singapore 95% 3,478 3,666
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (64%), P681R, R158-, T19R
Bahrain 88% 336 381
AY.4AY.4 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G (86%), F157- (86%), G142D (58%), P681R, R158- (86%), T19R, T95I (73%)
Maldives 88% 174 198
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (64%), P681R, R158-, T19R
Bangladesh 76% 275 360
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (64%), P681R, R158-, T19R
Sri Lanka 76% 364 481
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (64%), P681R, R158-, T19R
South Korea 75% 2,163 2,872
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (64%), P681R, R158-, T19R
Japan 72% 9,841 13,665
AY.23AY.23 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N (89%), E156G (79%), F157- (79%), G142D (58%), P681R, R158- (79%), T19R, V1264L (78%)
Indonesia 71% 584 819
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (64%), P681R, R158-, T19R
India 67% 1,566 2,340
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (64%), P681R, R158-, T19R
Malaysia 64% 421 655
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (64%), P681R, R158-, T19R
Thailand 63% 324 517
B.1.1.7B.1.1.7 Mutations
ProteinMutations
Spike (RBD)N501Y
Spike (non-RBD)A570D, D614G, D1118H, H69-, P681H, S982A, T716I, V70-, Y144-
Cambodia 58% 275 472
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (64%), P681R, R158-, T19R
Hong Kong 57% 48 84
AY.4AY.4 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G (86%), F157- (86%), G142D (58%), P681R, R158- (86%), T19R, T95I (73%)
Pakistan 47% 84 179
AY.12AY.12 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G (83%), F157- (84%), P681R, R158- (83%), T19R
Israel 46% 420 917
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (64%), P681R, R158-, T19R
Pakistan 45% 81 179
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (64%), P681R, R158-, T19R
Israel 35% 321 917
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (64%), P681R, R158-, T19R
Cambodia 31% 144 472
B.1.1.7B.1.1.7 Mutations
ProteinMutations
Spike (RBD)N501Y
Spike (non-RBD)A570D, D614G, D1118H, H69-, P681H, S982A, T716I, V70-, Y144-
Japan 26% 3,547 13,665
AY.23AY.23 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N (89%), E156G (79%), F157- (79%), G142D (58%), P681R, R158- (79%), T19R, V1264L (78%)
Malaysia 25% 167 655
B.1.1.7B.1.1.7 Mutations
ProteinMutations
Spike (RBD)N501Y
Spike (non-RBD)A570D, D614G, D1118H, H69-, P681H, S982A, T716I, V70-, Y144-
Thailand 24% 125 517
AY.24AY.24 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G (89%), F157- (89%), P681R, R158- (89%), T19R
Indonesia 23% 189 819
AY.4AY.4 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G (86%), F157- (86%), G142D (58%), P681R, R158- (86%), T19R, T95I (73%)
India 14% 325 2,340
AY.24AY.24 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G (89%), F157- (89%), P681R, R158- (89%), T19R
Hong Kong 13% 11 84
B.1.619.1B.1.619.1 Mutations
ProteinMutations
Spike (RBD)E484K, N440K
Spike (non-RBD)D614G, D936N, I210T, S939F, T1027I
South Korea 12% 345 2,872
AY.12AY.12 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G (83%), F157- (84%), P681R, R158- (83%), T19R
Bangladesh 11% 40 360
Q.8Q.8 Mutations
ProteinMutations
Spike (RBD)N501Y
Spike (non-RBD)A570D, D614G, H69-, P681H, V70-, Y144-
Sri Lanka 11% 52 481
*Criteria: Above 10%, minimum of 50 samples per country.
Lineage Country Percent Lineage Count Total Count
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (64%), P681R, R158-, T19R
New Zealand 88% 861 979
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (64%), P681R, R158-, T19R
Australia 79% 7,113 9,042
AY.4AY.4 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G (86%), F157- (86%), G142D (58%), P681R, R158- (86%), T19R, T95I (73%)
Australia 16% 1,479 9,042
*Criteria: Above 10%, minimum of 50 samples per country.
Lineage Country Percent Lineage Count Total Count
P.1P.1 Mutations
ProteinMutations
Spike (RBD)E484K, K417T, N501Y
Spike (non-RBD)D138Y, D614G, H655Y, L18F, P26S, R190S, T20N, T1027I, V1176F
Trinidad And Tobago 91% 74 81
P.1P.1 Mutations
ProteinMutations
Spike (RBD)E484K, K417T, N501Y
Spike (non-RBD)D138Y, D614G, H655Y, L18F, P26S, R190S, T20N, T1027I, V1176F
Suriname 77% 86 111
B.1.621B.1.621 Mutations
ProteinMutations
Spike (RBD)E484K, N501Y, R346K
Spike (non-RBD)D614G, D950N (90%), P681H, T95I, Y144T (77%), Y145S (70%), ins145N (76%)
Colombia 74% 213 289
AY.9AY.9 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)A222V, D614G, D950N, E156G, F157-, G142D (60%), P681R, R158-, T19R
Curacao 56% 116 206
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (64%), P681R, R158-, T19R
Brazil 55% 4,093 7,478
C.37C.37 Mutations
ProteinMutations
Spike (RBD)F490S, L452Q
Spike (non-RBD)D253N (86%), D614G, G75V, G252- (86%), L249- (86%), P251- (86%), R246- (86%), S247- (86%), T76I, T250- (86%), T859N, Y248- (86%)
Peru 54% 504 941
P.1P.1 Mutations
ProteinMutations
Spike (RBD)E484K, K417T, N501Y
Spike (non-RBD)D138Y, D614G, H655Y, L18F, P26S, R190S, T20N, T1027I, V1176F
Chile 53% 1,054 1,971
AY.9AY.9 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)A222V, D614G, D950N, E156G, F157-, G142D (60%), P681R, R158-, T19R
Bonaire 47% 54 116
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (64%), P681R, R158-, T19R
Paraguay 45% 30 67
P.1P.1 Mutations
ProteinMutations
Spike (RBD)E484K, K417T, N501Y
Spike (non-RBD)D138Y, D614G, H655Y, L18F, P26S, R190S, T20N, T1027I, V1176F
French Guiana 40% 135 334
AY.4AY.4 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G (86%), F157- (86%), G142D (58%), P681R, R158- (86%), T19R, T95I (73%)
Aruba 36% 435 1,217
AY.5AY.5 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G (87%), F157- (88%), G142D (68%), P681R, R158- (87%), T19R
Paraguay 34% 23 67
P.1P.1 Mutations
ProteinMutations
Spike (RBD)E484K, K417T, N501Y
Spike (non-RBD)D138Y, D614G, H655Y, L18F, P26S, R190S, T20N, T1027I, V1176F
Argentina 31% 45 144
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (64%), P681R, R158-, T19R
French Guiana 31% 103 334
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (64%), P681R, R158-, T19R
Curacao 30% 61 206
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (64%), P681R, R158-, T19R
Bonaire 29% 34 116
P.1P.1 Mutations
ProteinMutations
Spike (RBD)E484K, K417T, N501Y
Spike (non-RBD)D138Y, D614G, H655Y, L18F, P26S, R190S, T20N, T1027I, V1176F
Brazil 26% 1,948 7,478
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (64%), P681R, R158-, T19R
Aruba 23% 285 1,217
AY.4AY.4 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G (86%), F157- (86%), G142D (58%), P681R, R158- (86%), T19R, T95I (73%)
French Guiana 21% 71 334
AY.25AY.25 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (52%), P681R, R158-, T19R
Aruba 21% 256 1,217
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (64%), P681R, R158-, T19R
Argentina 20% 29 144
C.37C.37 Mutations
ProteinMutations
Spike (RBD)F490S, L452Q
Spike (non-RBD)D253N (86%), D614G, G75V, G252- (86%), L249- (86%), P251- (86%), R246- (86%), S247- (86%), T76I, T250- (86%), T859N, Y248- (86%)
Argentina 18% 26 144
C.37C.37 Mutations
ProteinMutations
Spike (RBD)F490S, L452Q
Spike (non-RBD)D253N (86%), D614G, G75V, G252- (86%), L249- (86%), P251- (86%), R246- (86%), S247- (86%), T76I, T250- (86%), T859N, Y248- (86%)
Chile 17% 328 1,971
AY.9AY.9 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)A222V, D614G, D950N, E156G, F157-, G142D (60%), P681R, R158-, T19R
Aruba 16% 198 1,217
AY.12AY.12 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G (83%), F157- (84%), P681R, R158- (83%), T19R
Ecuador 16% 74 468
B.1.621B.1.621 Mutations
ProteinMutations
Spike (RBD)E484K, N501Y, R346K
Spike (non-RBD)D614G, D950N (90%), P681H, T95I, Y144T (77%), Y145S (70%), ins145N (76%)
Ecuador 15% 72 468
P.1P.1 Mutations
ProteinMutations
Spike (RBD)E484K, K417T, N501Y
Spike (non-RBD)D138Y, D614G, H655Y, L18F, P26S, R190S, T20N, T1027I, V1176F
Peru 15% 144 941
B.1B.1 Mutations
ProteinMutations
Spike (non-RBD)D614G
Ecuador 15% 68 468
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (64%), P681R, R158-, T19R
Suriname 13% 14 111
C.37C.37 Mutations
ProteinMutations
Spike (RBD)F490S, L452Q
Spike (non-RBD)D253N (86%), D614G, G75V, G252- (86%), L249- (86%), P251- (86%), R246- (86%), S247- (86%), T76I, T250- (86%), T859N, Y248- (86%)
Ecuador 12% 57 468
B.1.526B.1.526 Mutations
ProteinMutations
Spike (RBD)E484K (55%)
Spike (non-RBD)A701V (64%), D253G, D614G, L5F, T95I
Ecuador 11% 51 468
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (64%), P681R, R158-, T19R
Peru 10% 98 941
AY.5AY.5 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G (87%), F157- (88%), G142D (68%), P681R, R158- (87%), T19R
Bonaire 10% 12 116
AY.25AY.25 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (52%), P681R, R158-, T19R
Bonaire 10% 12 116
*Criteria: Above 10%, minimum of 50 samples per country.
Lineage Country Percent Lineage Count Total Count
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (64%), P681R, R158-, T19R
Togo 91% 62 68
AY.4AY.4 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G (86%), F157- (86%), G142D (58%), P681R, R158- (86%), T19R, T95I (73%)
Botswana 75% 256 340
AY.4AY.4 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G (86%), F157- (86%), G142D (58%), P681R, R158- (86%), T19R, T95I (73%)
Zimbabwe 68% 36 53
AY.20AY.20 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N (90%), E156G, F157-, P681R, R158-, T19R, T95I (66%), V1104L
Nigeria 43% 262 608
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (64%), P681R, R158-, T19R
France (Réunion Island) 42% 22 53
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (64%), P681R, R158-, T19R
South Africa 40% 1,304 3,223
AY.4AY.4 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G (86%), F157- (86%), G142D (58%), P681R, R158- (86%), T19R, T95I (73%)
Kenya 39% 166 422
AY.4AY.4 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G (86%), F157- (86%), G142D (58%), P681R, R158- (86%), T19R, T95I (73%)
South Africa 38% 1,216 3,223
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (64%), P681R, R158-, T19R
Ghana 38% 87 232
B.1.351.2B.1.351.2 Mutations
ProteinMutations
Spike (RBD)E484K (88%), K417N, N501Y (89%)
Spike (non-RBD)A243-, A701V, D80A, D215G, D614G, L18F, L242-, L244-
Reunion 37% 77 209
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (64%), P681R, R158-, T19R
Reunion 35% 74 209
B.1.351.2B.1.351.2 Mutations
ProteinMutations
Spike (RBD)E484K (88%), K417N, N501Y (89%)
Spike (non-RBD)A243-, A701V, D80A, D215G, D614G, L18F, L242-, L244-
France (Réunion Island) 30% 16 53
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (64%), P681R, R158-, T19R
Kenya 27% 116 422
AY.16AY.16 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N (84%), E156G (60%), F157- (61%), P681R, R158- (61%), T19R
Kenya 26% 109 422
B.1.351B.1.351 Mutations
ProteinMutations
Spike (RBD)E484K (87%), K417N (89%), N501Y (88%)
Spike (non-RBD)A243- (80%), A701V, D80A (88%), D215G (86%), D614G, L242- (79%), L244- (76%)
France (Réunion Island) 25% 13 53
B.1.351B.1.351 Mutations
ProteinMutations
Spike (RBD)E484K (87%), K417N (89%), N501Y (88%)
Spike (non-RBD)A243- (80%), A701V, D80A (88%), D215G (86%), D614G, L242- (79%), L244- (76%)
Reunion 23% 49 209
AY.7.1AY.7.1 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G (63%), F157- (63%), P681R, R158- (63%), T19R
Ghana 23% 53 232
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (64%), P681R, R158-, T19R
Nigeria 22% 131 608
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (64%), P681R, R158-, T19R
Botswana 21% 70 340
AY.25AY.25 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (52%), P681R, R158-, T19R
Ghana 14% 33 232
AY.10AY.10 Mutations
ProteinMutations
Spike (RBD)L452R (70%), T478K (69%)
Spike (non-RBD)D614G, D950N, E156G, F157-, P681R, R158-, T19R
Zimbabwe 13% 7 53
AY.4AY.4 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G (86%), F157- (86%), G142D (58%), P681R, R158- (86%), T19R, T95I (73%)
Nigeria 12% 73 608
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (64%), P681R, R158-, T19R
Zimbabwe 11% 6 53
*Criteria: Above 10%, minimum of 50 samples per country.
Lineage State Percent Lineage Count Total Count
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (64%), P681R, R158-, T19R
Idaho 81% 2,334 2,864
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (64%), P681R, R158-, T19R
New Mexico 71% 1,629 2,286
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (64%), P681R, R158-, T19R
North Carolina 71% 7,728 10,940
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (64%), P681R, R158-, T19R
Utah 69% 5,359 7,797
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (64%), P681R, R158-, T19R
South Carolina 69% 2,619 3,821
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (64%), P681R, R158-, T19R
Florida 67% 16,797 25,109
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (64%), P681R, R158-, T19R
Nevada 67% 3,146 4,730
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (64%), P681R, R158-, T19R
California 66% 38,948 59,088
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (64%), P681R, R158-, T19R
Virginia 66% 3,009 4,589
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (64%), P681R, R158-, T19R
Montana 65% 727 1,116
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (64%), P681R, R158-, T19R
West Virginia 65% 644 994
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (64%), P681R, R158-, T19R
Delaware 62% 387 620
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (64%), P681R, R158-, T19R
Pennsylvania 62% 1,483 2,381
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (64%), P681R, R158-, T19R
Indiana 62% 1,931 3,110
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (64%), P681R, R158-, T19R
Alabama 62% 3,083 4,966
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (64%), P681R, R158-, T19R
Georgia 59% 5,841 9,823
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (64%), P681R, R158-, T19R
Iowa 59% 1,488 2,534
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (64%), P681R, R158-, T19R
New York 58% 6,978 12,082
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (64%), P681R, R158-, T19R
Arizona 58% 4,031 7,008
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (64%), P681R, R158-, T19R
Hawaii 57% 514 897
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (64%), P681R, R158-, T19R
Wisconsin 57% 2,467 4,346
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (64%), P681R, R158-, T19R
District of Columbia 57% 552 976
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (64%), P681R, R158-, T19R
Maryland 56% 2,722 4,821
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (64%), P681R, R158-, T19R
Maine 56% 792 1,411
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (64%), P681R, R158-, T19R
Ohio 56% 2,001 3,587
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (64%), P681R, R158-, T19R
Illinois 56% 3,502 6,278
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (64%), P681R, R158-, T19R
Kentucky 54% 1,392 2,560
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (64%), P681R, R158-, T19R
Colorado 54% 3,681 6,847
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (64%), P681R, R158-, T19R
Tennessee 54% 2,072 3,865
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (64%), P681R, R158-, T19R
New Jersey 52% 3,304 6,295
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (64%), P681R, R158-, T19R
Connecticut 52% 1,912 3,671
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (64%), P681R, R158-, T19R
Texas 52% 8,487 16,306
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (64%), P681R, R158-, T19R
Oklahoma 51% 389 757
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (64%), P681R, R158-, T19R
South Dakota 51% 292 570
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (64%), P681R, R158-, T19R
Oregon 50% 2,329 4,647
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (64%), P681R, R158-, T19R
Vermont 50% 848 1,707
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (64%), P681R, R158-, T19R
Kansas 48% 1,622 3,374
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (64%), P681R, R158-, T19R
Minnesota 48% 4,186 8,716
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (64%), P681R, R158-, T19R
US Virgin Islands 48% 22 46
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (64%), P681R, R158-, T19R
New Hampshire 46% 230 501
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (64%), P681R, R158-, T19R
Nebraska 45% 863 1,903
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (64%), P681R, R158-, T19R
Alaska 43% 885 2,042
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (64%), P681R, R158-, T19R
North Dakota 43% 479 1,119
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (64%), P681R, R158-, T19R
Rhode Island 42% 667 1,575
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (64%), P681R, R158-, T19R
Arkansas 42% 1,750 4,213
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (64%), P681R, R158-, T19R
Missouri 41% 1,639 4,038
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (64%), P681R, R158-, T19R
Washington 40% 4,327 10,921
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (64%), P681R, R158-, T19R
Michigan 40% 1,035 2,619
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (64%), P681R, R158-, T19R
Massachusetts 37% 5,313 14,431
AY.25AY.25 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (52%), P681R, R158-, T19R
Louisiana 35% 1,751 4,950
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (64%), P681R, R158-, T19R
Wyoming 34% 813 2,405
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (64%), P681R, R158-, T19R
Mississippi 33% 1,085 3,247
*Criteria: Minimum of 20 samples per state.

Top Emerging* Lineages (Past 12 Weeks)

Lineage Country 2-Week Period Change Previous Support Current Support
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (64%), P681R, R158-, T19R
Turkey 2021-08-09 29% -> 84% (+55%) 3,570 / 12,168 28,886 / 34,333
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (64%), P681R, R158-, T19R
Slovenia 2021-08-23 41% -> 66% (+24%) 826 / 1,998 526 / 802
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (64%), P681R, R158-, T19R
Luxembourg 2021-07-26 36% -> 58% (+22%) 250 / 699 149 / 257
AY.4AY.4 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G (86%), F157- (86%), G142D (58%), P681R, R158- (86%), T19R, T95I (73%)
Iceland 2021-08-23 7% -> 28% (+20%) 94 / 1,262 111 / 398
AY.4AY.4 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G (86%), F157- (86%), G142D (58%), P681R, R158- (86%), T19R, T95I (73%)
Bulgaria 2021-08-09 34% -> 50% (+16%) 129 / 376 10 / 20
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (64%), P681R, R158-, T19R
Greece 2021-07-26 30% -> 44% (+15%) 121 / 408 116 / 262
AY.12AY.12 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G (83%), F157- (84%), P681R, R158- (83%), T19R
Russia 2021-07-26 21% -> 36% (+14%) 34 / 159 61 / 171
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (64%), P681R, R158-, T19R
Sweden 2021-07-26 57% -> 71% (+14%) 1,903 / 3,336 3,255 / 4,580
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (64%), P681R, R158-, T19R
Poland 2021-07-26 33% -> 47% (+14%) 80 / 239 157 / 333
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (64%), P681R, R158-, T19R
Denmark 2021-07-26 41% -> 54% (+14%) 4,345 / 10,657 5,801 / 10,660
AY.4AY.4 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G (86%), F157- (86%), G142D (58%), P681R, R158- (86%), T19R, T95I (73%)
Romania 2021-09-06 20% -> 33% (+13%) 42 / 211 41 / 126
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (64%), P681R, R158-, T19R
Austria 2021-08-23 12% -> 24% (+12%) 65 / 563 16 / 67
AY.9AY.9 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)A222V, D614G, D950N, E156G, F157-, G142D (60%), P681R, R158-, T19R
Gibraltar 2021-08-23 17% -> 28% (+11%) 23 / 137 26 / 92
AY.9AY.9 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)A222V, D614G, D950N, E156G, F157-, G142D (60%), P681R, R158-, T19R
Slovakia 2021-07-26 7% -> 18% (+11%) 19 / 270 68 / 370
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (64%), P681R, R158-, T19R
Switzerland 2021-09-06 52% -> 63% (+11%) 1,152 / 2,232 134 / 213
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (64%), P681R, R158-, T19R
Portugal 2021-07-26 38% -> 49% (+11%) 476 / 1,248 469 / 954
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (64%), P681R, R158-, T19R
Italy 2021-07-26 55% -> 66% (+11%) 2,435 / 4,394 2,555 / 3,849
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (64%), P681R, R158-, T19R
Spain 2021-09-06 69% -> 79% (+9%) 880 / 1,267 60 / 76
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (64%), P681R, R158-, T19R
Netherlands 2021-08-09 52% -> 61% (+9%) 2,011 / 3,857 1,851 / 3,027
AY.4AY.4 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G (86%), F157- (86%), G142D (58%), P681R, R158- (86%), T19R, T95I (73%)
Czechia 2021-08-09 14% -> 22% (+8%) 64 / 471 73 / 336
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (64%), P681R, R158-, T19R
Finland 2021-08-09 37% -> 45% (+8%) 338 / 916 371 / 825
AY.4AY.4 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G (86%), F157- (86%), G142D (58%), P681R, R158- (86%), T19R, T95I (73%)
Lithuania 2021-07-26 80% -> 88% (+8%) 789 / 990 1,328 / 1,514
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (64%), P681R, R158-, T19R
Norway 2021-08-09 67% -> 73% (+7%) 867 / 1,301 1,083 / 1,476
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (64%), P681R, R158-, T19R
France 2021-08-09 71% -> 77% (+6%) 6,423 / 9,009 1,534 / 1,987
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (64%), P681R, R158-, T19R
Estonia 2021-07-26 88% -> 94% (+6%) 222 / 251 339 / 360
AY.4AY.4 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G (86%), F157- (86%), G142D (58%), P681R, R158- (86%), T19R, T95I (73%)
Belgium 2021-09-06 14% -> 19% (+5%) 351 / 2,537 100 / 527
AY.5AY.5 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G (87%), F157- (88%), G142D (68%), P681R, R158- (87%), T19R
Croatia 2021-08-09 1% -> 4% (+3%) 6 / 468 6 / 142
*Criteria: >= +5% or >= 2x fold change between 2 week periods with >= 20 samples.
Lineage Country 2-Week Period Change Previous Support Current Support
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (64%), P681R, R158-, T19R
France (Martinique) 2021-07-26 4% -> 45% (+42%) 2 / 56 10 / 22
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (64%), P681R, R158-, T19R
The Bahamas 2021-07-26 38% -> 74% (+37%) 12 / 32 20 / 27
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (64%), P681R, R158-, T19R
Martinique 2021-07-26 16% -> 49% (+33%) 9 / 58 24 / 49
AY.9AY.9 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)A222V, D614G, D950N, E156G, F157-, G142D (60%), P681R, R158-, T19R
Sint Maarten 2021-07-26 18% -> 48% (+30%) 12 / 67 120 / 249
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (64%), P681R, R158-, T19R
Guatemala 2021-07-26 29% -> 53% (+24%) 11 / 38 35 / 66
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (64%), P681R, R158-, T19R
Guadeloupe 2021-08-09 61% -> 84% (+23%) 31 / 51 48 / 57
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (64%), P681R, R158-, T19R
Canada 2021-08-09 45% -> 65% (+20%) 3,258 / 7,192 1,606 / 2,467
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (64%), P681R, R158-, T19R
U.S. Virgin Islands 2021-08-09 32% -> 51% (+19%) 34 / 107 34 / 67
AY.20AY.20 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N (90%), E156G, F157-, P681R, R158-, T19R, T95I (66%), V1104L
Mexico 2021-09-06 53% -> 67% (+14%) 480 / 913 120 / 180
P.1P.1 Mutations
ProteinMutations
Spike (RBD)E484K, K417T, N501Y
Spike (non-RBD)D138Y, D614G, H655Y, L18F, P26S, R190S, T20N, T1027I, V1176F
Costa Rica 2021-07-26 9% -> 23% (+14%) 8 / 86 29 / 124
AY.25AY.25 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (52%), P681R, R158-, T19R
Puerto Rico 2021-08-09 8% -> 19% (+10%) 29 / 344 28 / 148
*Criteria: >= +5% or >= 2x fold change between 2 week periods with >= 20 samples.
Lineage Country 2-Week Period Change Previous Support Current Support
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (64%), P681R, R158-, T19R
Sri Lanka 2021-07-26 41% -> 87% (+46%) 33 / 80 102 / 117
AY.23AY.23 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N (89%), E156G (79%), F157- (79%), G142D (58%), P681R, R158- (79%), T19R, V1264L (78%)
Malaysia 2021-07-26 3% -> 37% (+34%) 4 / 141 89 / 243
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (64%), P681R, R158-, T19R
Pakistan 2021-08-23 31% -> 62% (+31%) 18 / 58 24 / 39
B.1.351B.1.351 Mutations
ProteinMutations
Spike (RBD)E484K (87%), K417N (89%), N501Y (88%)
Spike (non-RBD)A243- (80%), A701V, D80A (88%), D215G (86%), D614G, L242- (79%), L244- (76%)
Thailand 2021-08-23 1% -> 29% (+28%) 1 / 167 9 / 31
AY.4AY.4 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G (86%), F157- (86%), G142D (58%), P681R, R158- (86%), T19R, T95I (73%)
Maldives 2021-08-09 62% -> 90% (+28%) 15 / 24 46 / 51
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (64%), P681R, R158-, T19R
South Korea 2021-07-26 58% -> 79% (+21%) 595 / 1,031 676 / 854
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (64%), P681R, R158-, T19R
Japan 2021-07-26 60% -> 80% (+20%) 3,302 / 5,527 6,202 / 7,750
B.1.1.7B.1.1.7 Mutations
ProteinMutations
Spike (RBD)N501Y
Spike (non-RBD)A570D, D614G, D1118H, H69-, P681H, S982A, T716I, V70-, Y144-
Cambodia 2021-08-09 49% -> 67% (+18%) 43 / 87 71 / 106
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (64%), P681R, R158-, T19R
Hong Kong 2021-08-09 58% -> 74% (+16%) 15 / 26 20 / 27
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (64%), P681R, R158-, T19R
India 2021-08-23 72% -> 86% (+14%) 182 / 253 25 / 29
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (64%), P681R, R158-, T19R
Singapore 2021-08-09 2% -> 14% (+13%) 15 / 864 94 / 654
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (64%), P681R, R158-, T19R
Bahrain 2021-08-23 81% -> 92% (+10%) 39 / 48 208 / 227
AY.12AY.12 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G (83%), F157- (84%), P681R, R158- (83%), T19R
Israel 2021-07-26 40% -> 50% (+9%) 118 / 293 214 / 430
AY.23AY.23 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N (89%), E156G (79%), F157- (79%), G142D (58%), P681R, R158- (79%), T19R, V1264L (78%)
Indonesia 2021-07-26 67% -> 76% (+9%) 277 / 414 207 / 273
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (64%), P681R, R158-, T19R
Bangladesh 2021-07-26 72% -> 80% (+8%) 124 / 172 96 / 120
*Criteria: >= +5% or >= 2x fold change between 2 week periods with >= 20 samples.
Lineage Country 2-Week Period Change Previous Support Current Support
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (64%), P681R, R158-, T19R
New Zealand 2021-07-26 27% -> 60% (+33%) 13 / 49 18 / 30
AY.4AY.4 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G (86%), F157- (86%), G142D (58%), P681R, R158- (86%), T19R, T95I (73%)
Australia 2021-08-09 11% -> 21% (+10%) 293 / 2,595 570 / 2,728
*Criteria: >= +5% or >= 2x fold change between 2 week periods with >= 20 samples.
Lineage Country 2-Week Period Change Previous Support Current Support
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (64%), P681R, R158-, T19R
French Guiana 2021-09-06 26% -> 73% (+47%) 6 / 23 22 / 30
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (64%), P681R, R158-, T19R
Bonaire 2021-08-09 12% -> 47% (+34%) 5 / 40 21 / 45
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (64%), P681R, R158-, T19R
Brazil 2021-07-26 23% -> 46% (+23%) 402 / 1,750 837 / 1,836
B.1B.1 Mutations
ProteinMutations
Spike (non-RBD)D614G
Ecuador 2021-07-26 7% -> 28% (+21%) 21 / 314 25 / 89
AY.4AY.4 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G (86%), F157- (86%), G142D (58%), P681R, R158- (86%), T19R, T95I (73%)
Aruba 2021-07-26 25% -> 45% (+20%) 25 / 100 221 / 490
B.1.1B.1.1 Mutations
ProteinMutations
Spike (non-RBD)D614G
Chile 2021-08-23 1% -> 18% (+18%) 3 / 529 26 / 142
P.1P.1 Mutations
ProteinMutations
Spike (RBD)E484K, K417T, N501Y
Spike (non-RBD)D138Y, D614G, H655Y, L18F, P26S, R190S, T20N, T1027I, V1176F
Peru 2021-08-09 6% -> 23% (+17%) 15 / 252 50 / 216
P.1P.1 Mutations
ProteinMutations
Spike (RBD)E484K, K417T, N501Y
Spike (non-RBD)D138Y, D614G, H655Y, L18F, P26S, R190S, T20N, T1027I, V1176F
Trinidad And Tobago 2021-08-09 86% -> 100% (+14%) 42 / 49 21 / 21
AY.9AY.9 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)A222V, D614G, D950N, E156G, F157-, G142D (60%), P681R, R158-, T19R
Curacao 2021-07-26 48% -> 60% (+13%) 32 / 67 55 / 91
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (64%), P681R, R158-, T19R
Suriname 2021-08-09 16% -> 23% (+7%) 8 / 50 6 / 26
C.37C.37 Mutations
ProteinMutations
Spike (RBD)F490S, L452Q
Spike (non-RBD)D253N (86%), D614G, G75V, G252- (86%), L249- (86%), P251- (86%), R246- (86%), S247- (86%), T76I, T250- (86%), T859N, Y248- (86%)
Argentina 2021-07-26 15% -> 21% (+7%) 15 / 102 6 / 28
AY.25AY.25 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (52%), P681R, R158-, T19R
Colombia 2021-07-26 2% -> 8% (+6%) 4 / 160 7 / 85
*Criteria: >= +5% or >= 2x fold change between 2 week periods with >= 20 samples.
Lineage Country 2-Week Period Change Previous Support Current Support
AY.20AY.20 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N (90%), E156G, F157-, P681R, R158-, T19R, T95I (66%), V1104L
Nigeria 2021-07-26 4% -> 52% (+48%) 3 / 71 164 / 315
AY.4AY.4 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G (86%), F157- (86%), G142D (58%), P681R, R158- (86%), T19R, T95I (73%)
Kenya 2021-07-26 24% -> 59% (+34%) 34 / 141 82 / 140
AY.7.1AY.7.1 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G (63%), F157- (63%), P681R, R158- (63%), T19R
Ghana 2021-08-09 17% -> 38% (+22%) 13 / 78 18 / 47
AY.4AY.4 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G (86%), F157- (86%), G142D (58%), P681R, R158- (86%), T19R, T95I (73%)
South Africa 2021-08-09 37% -> 55% (+18%) 422 / 1,130 286 / 517
AY.4AY.4 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G (86%), F157- (86%), G142D (58%), P681R, R158- (86%), T19R, T95I (73%)
Botswana 2021-08-09 69% -> 83% (+14%) 20 / 29 68 / 82
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (64%), P681R, R158-, T19R
Togo 2021-07-26 83% -> 95% (+12%) 20 / 24 42 / 44
*Criteria: >= +5% or >= 2x fold change between 2 week periods with >= 20 samples.
Lineage State 2-Week Period Change Previous Support Current Support
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (64%), P681R, R158-, T19R
Vermont 2021-08-23 26% -> 70% (+44%) 145 / 560 546 / 781
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (64%), P681R, R158-, T19R
Connecticut 2021-09-06 50% -> 87% (+37%) 355 / 717 26 / 30
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (64%), P681R, R158-, T19R
Minnesota 2021-09-06 51% -> 83% (+33%) 699 / 1,379 20 / 24
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (64%), P681R, R158-, T19R
South Dakota 2021-08-23 40% -> 69% (+29%) 90 / 225 49 / 71
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (64%), P681R, R158-, T19R
Massachusetts 2021-08-23 29% -> 54% (+25%) 1,326 / 4,624 2,492 / 4,628
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (64%), P681R, R158-, T19R
Louisiana 2021-09-06 36% -> 60% (+24%) 140 / 393 12 / 20
AY.4AY.4 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G (86%), F157- (86%), G142D (58%), P681R, R158- (86%), T19R, T95I (73%)
Washington 2021-08-23 26% -> 45% (+19%) 915 / 3,480 548 / 1,208
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (64%), P681R, R158-, T19R
Oregon 2021-07-26 35% -> 51% (+16%) 387 / 1,094 944 / 1,848
AY.3AY.3 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (54%), P681R, R158-, T19R
Arizona 2021-09-06 8% -> 22% (+14%) 112 / 1,421 31 / 139
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (64%), P681R, R158-, T19R
Oklahoma 2021-07-26 44% -> 57% (+13%) 92 / 210 187 / 329
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (64%), P681R, R158-, T19R
Maine 2021-08-23 57% -> 70% (+13%) 310 / 540 89 / 127
AY.25AY.25 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (52%), P681R, R158-, T19R
New Hampshire 2021-07-26 28% -> 41% (+12%) 11 / 39 43 / 106
AY.5AY.5 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G (87%), F157- (88%), G142D (68%), P681R, R158- (87%), T19R
Montana 2021-08-09 4% -> 16% (+12%) 16 / 426 49 / 305
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (64%), P681R, R158-, T19R
District of Columbia 2021-08-23 57% -> 68% (+11%) 215 / 377 81 / 119
AY.25AY.25 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (52%), P681R, R158-, T19R
Illinois 2021-09-06 13% -> 24% (+11%) 54 / 422 9 / 38
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (64%), P681R, R158-, T19R
Maryland 2021-07-26 49% -> 60% (+10%) 493 / 998 1,271 / 2,135
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (64%), P681R, R158-, T19R
Nebraska 2021-07-26 37% -> 47% (+10%) 147 / 398 172 / 369
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (64%), P681R, R158-, T19R
South Carolina 2021-07-26 62% -> 71% (+10%) 398 / 645 928 / 1,301
AY.25AY.25 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (52%), P681R, R158-, T19R
Rhode Island 2021-07-26 19% -> 29% (+9%) 46 / 240 171 / 598
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (64%), P681R, R158-, T19R
Alaska 2021-07-26 34% -> 43% (+9%) 211 / 620 154 / 356
AY.4AY.4 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G (86%), F157- (86%), G142D (58%), P681R, R158- (86%), T19R, T95I (73%)
Arkansas 2021-08-23 24% -> 32% (+9%) 245 / 1,034 201 / 620
AY.25AY.25 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (52%), P681R, R158-, T19R
Wisconsin 2021-09-06 21% -> 30% (+9%) 59 / 282 13 / 44
AY.12AY.12 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G (83%), F157- (84%), P681R, R158- (83%), T19R
North Dakota 2021-08-23 18% -> 26% (+8%) 90 / 503 25 / 95
AY.3AY.3 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (54%), P681R, R158-, T19R
Iowa 2021-09-06 18% -> 26% (+8%) 113 / 625 27 / 102
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (64%), P681R, R158-, T19R
Tennessee 2021-08-09 50% -> 58% (+8%) 987 / 1,974 513 / 881
AY.25AY.25 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (52%), P681R, R158-, T19R
Ohio 2021-07-26 7% -> 15% (+8%) 33 / 498 206 / 1,402
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (64%), P681R, R158-, T19R
New Jersey 2021-07-26 45% -> 53% (+8%) 692 / 1,548 1,372 / 2,603
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (64%), P681R, R158-, T19R
New York 2021-07-26 50% -> 58% (+8%) 953 / 1,893 2,271 / 3,894
AY.3AY.3 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (54%), P681R, R158-, T19R
Nevada 2021-09-06 6% -> 13% (+8%) 25 / 453 7 / 52
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (64%), P681R, R158-, T19R
Kansas 2021-09-06 51% -> 59% (+8%) 275 / 535 150 / 253
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (64%), P681R, R158-, T19R
Delaware 2021-08-09 60% -> 68% (+8%) 103 / 171 169 / 249
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (64%), P681R, R158-, T19R
Mississippi 2021-07-26 26% -> 34% (+8%) 137 / 522 338 / 999
AY.4AY.4 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G (86%), F157- (86%), G142D (58%), P681R, R158- (86%), T19R, T95I (73%)
Michigan 2021-08-09 28% -> 35% (+7%) 262 / 936 283 / 804
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (64%), P681R, R158-, T19R
West Virginia 2021-08-09 62% -> 69% (+7%) 150 / 242 369 / 537
AY.3AY.3 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (54%), P681R, R158-, T19R
Wyoming 2021-07-26 3% -> 9% (+6%) 12 / 411 53 / 571
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (64%), P681R, R158-, T19R
Georgia 2021-07-26 53% -> 59% (+6%) 763 / 1,445 2,693 / 4,567
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (64%), P681R, R158-, T19R
Virginia 2021-08-23 63% -> 69% (+6%) 792 / 1,251 298 / 430
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (64%), P681R, R158-, T19R
Hawaii 2021-08-09 54% -> 60% (+6%) 178 / 329 54 / 90
AY.25AY.25 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (52%), P681R, R158-, T19R
Indiana 2021-08-23 11% -> 17% (+6%) 106 / 931 71 / 416
AY.12AY.12 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G (83%), F157- (84%), P681R, R158- (83%), T19R
New Mexico 2021-08-23 3% -> 9% (+6%) 28 / 830 17 / 189
B.1.617.2B.1.617.2 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (64%), P681R, R158-, T19R
Colorado 2021-08-09 53% -> 58% (+6%) 1,550 / 2,952 561 / 967
AY.25AY.25 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (52%), P681R, R158-, T19R
Kentucky 2021-08-23 19% -> 25% (+5%) 215 / 1,116 101 / 410
AY.25AY.25 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (52%), P681R, R158-, T19R
Missouri 2021-07-26 3% -> 8% (+5%) 35 / 1,213 129 / 1,588
AY.25AY.25 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G, F157-, G142D (52%), P681R, R158-, T19R
Idaho 2021-07-26 2% -> 6% (+4%) 13 / 626 81 / 1,377
AY.7.1AY.7.1 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G (63%), F157- (63%), P681R, R158- (63%), T19R
Alabama 2021-07-26 2% -> 5% (+3%) 19 / 947 116 / 2,374
AY.10AY.10 Mutations
ProteinMutations
Spike (RBD)L452R (70%), T478K (69%)
Spike (non-RBD)D614G, D950N, E156G, F157-, P681R, R158-, T19R
California 2021-08-23 1% -> 3% (+3%) 94 / 16,047 250 / 7,829
AY.24AY.24 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G (89%), F157- (89%), P681R, R158- (89%), T19R
Pennsylvania 2021-08-23 1% -> 2% (+2%) 6 / 938 6 / 268
AY.4AY.4 Mutations
ProteinMutations
Spike (RBD)L452R, T478K
Spike (non-RBD)D614G, D950N, E156G (86%), F157- (86%), G142D (58%), P681R, R158- (86%), T19R, T95I (73%)
Texas 2021-07-26 1% -> 2% (+1%) 29 / 3,835 159 / 7,174
*Criteria: >= +5% or >= 2x fold change between 2-week periods with >= 20 samples.

Data Timeline

Loading...
Loading...

Dashboard Timeline

April 16, 2021
08:50PM

Dashboard UI/graphs updated

Added emerging lineages tracking and top lineages tracking per US state to home page
April 16, 2021
08:00PM

Dashboard backend pipeline overhauled

Overhauled backend pipeline to automatically download and QC data from GISAID daily
April 05, 2021
03:30PM

Dashboard UI/graphs updated

Added top and emerging lineage maps and graphs. Overhauled home page
March 23, 2021
06:00PM

Dashboard performance overhauled

Added caching and refactored all graphs for performance before public release
November 13, 2020
04:00PM

Dashboard UI/graphs updated

Broad-scale update across the entire dashboard to prepare for its launch onto the world wide web!
June 15, 2020
12:00AM

Dashboard graphs upgraded

Migrated dashboard graphs from Plotly to ECharts
June 04, 2020
08:06PM

Dashboard data source changed

Upgraded dashboard to use a database vs flat files. 3x reduction in load time
June 02, 2020
12:18PM

Dashboard UI upgraded

Overhauled dashboard user interface to use bs4dash
May 26, 2020
12:00AM

Variant tracking expanded

Began tracking variants in genes ORF1a and ORF1b
May 11, 2020
12:00AM

Variant tracking expanded

Began tracking variants in genes E, M, N, ORF3a, ORF7a, ORF8, and ORF10
April 27, 2020
12:00AM

Phylogenetic analysis added

Added tab containing viral genome evolutionary relationships
April 03, 2020
12:00AM

Automated QC pipeline created

Cleans up metadata fields such as age, collection date, gender, etc
April 02, 2020
10:36AM

First version of dashboard created

Created first version with shinydashboard. Data is ingested from flat files
March 31, 2020
12:00AM

Patient metadata tracking started

Began downloading patient metadata for all genomes
January 10, 2020
12:00AM

First data downloaded

Began downloading genomes from GISAID and subsequent variant calling



Loading...

Loading...